Highlights: Retatrutide targets GLP-1, GIP, and glucagon to reduce appetite, regulate fat storage, and manage blood sugar A trial showed a higher dose of Retatrutide produced 20% more weight loss over 48 weeks Common side effects include diarrhea, nausea, and vomiting , with at least one death reported Trusted Source Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial Go to source)
Diabetologia 58 , 17591768 (2015)
Each author participated sufficiently in the work to take public responsibility for appropriate portions of the content
Foods high in fiber include nuts, seeds, berries, and vegetables like broccoli
This is receptor adaptation, not a results phase
The mechanistic contrast with tirzepatide is covered in detail in retatrutide vs tirzepatide